Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Anne Flörcken, Joachim Kopp, Uwe Kölsch, Christian Meisel, Bernd Dörken, Antonio Pezzutto & Jörg Westermann. (2016) DC generation from peripheral blood mononuclear cells in patients with chronic myeloid leukemia: Influence of interferons on DC yield and functional properties. Human Vaccines & Immunotherapeutics 12:5, pages 1117-1123.
Read now
Read now
R Casalegno-Garduño, A Schmitt & M Schmitt. (2011) Clinical peptide vaccination trials for leukemia patients. Expert Review of Vaccines 10:6, pages 785-799.
Read now
Read now
Michael Schmitt, Rosaely Casalegno-Garduño, Xun Xu & Anita Schmitt. (2009) Peptide vaccines for patients with acute myeloid leukemia. Expert Review of Vaccines 8:10, pages 1415-1425.
Read now
Read now
Articles from other publishers (17)
Wensi Liu, Haichao Tang, Luanfeng Li, Xiangyi Wang, Zhaojin Yu & Jianping Li. (2021) Peptide‐based therapeutic cancer vaccine: Current trends in clinical application. Cell Proliferation 54:5.
Crossref
Crossref
Concetta Di Natale, Sara La Manna, Ilaria De Benedictis, Paola Brandi & Daniela Marasco. (2020) Perspectives in Peptide-Based Vaccination Strategies for Syndrome Coronavirus 2 Pandemic. Frontiers in Pharmacology 11.
Crossref
Crossref
He Cui, Xi Lan, Shemin Lu, Fujun Zhang & Wanggang Zhang. (2017) Bioinformatic prediction and functional characterization of human KIAA0100 gene. Journal of Pharmaceutical Analysis 7:1, pages 10-18.
Crossref
Crossref
Gerrit Weber, Catherine M. Bollard & Austin John Barrett. 2015. Targeted Therapy of Acute Myeloid Leukemia. Targeted Therapy of Acute Myeloid Leukemia
757
776
.
Hyoung Jin Kang, Cliona M. Rooney & Helen E. Heslop. 2013. Childhood Leukemias. Childhood Leukemias
582
592
.
R. Casalegno-Garduño, C. Meier, A. Schmitt, A. Spitschak, I. Hilgendorf, S. Rohde, C. Hirt, M. Freund, B. M. Pützer & M. Schmitt. (2012) Immune Responses to RHAMM in Patients with Acute Myeloid Leukemia after Chemotherapy and Allogeneic Stem Cell Transplantation. Clinical and Developmental Immunology 2012, pages 1-9.
Crossref
Crossref
Evelien L. J. Smits, Cindy Lee, Nicola Hardwick, Suzanne Brooks, Viggo F. I. Van Tendeloo, Kim Orchard & Barbara-ann Guinn. (2011) Clinical evaluation of cellular immunotherapy in acute myeloid leukaemia. Cancer Immunology, Immunotherapy 60:6, pages 757-769.
Crossref
Crossref
Simrit Parmar, Marcelo Fernandez-Vina & Marcos de Lima. (2011) Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia. Current Opinion in Hematology 18:2, pages 98-104.
Crossref
Crossref
Jos? M. Rojas, Katy Knight, Sarah Watmough, Joanne Bell, Lihui Wang, Therese Callaghan & Richard E. Clark. (2011) BCR-ABL peptide vaccination in healthy subjects: Immunological responses are equivalent to those in chronic myeloid leukaemia patients. Leukemia Research 35:3, pages 369-372.
Crossref
Crossref
Jan W. Gratama, Cor H. J. Lamers & Reno Debets. 2011. Principles of Immunopharmacology. Principles of Immunopharmacology
151
178
.
Rosaely Casalegno-Garduño, Anita Schmitt, Xinchao Wang, Xun Xu & Michael Schmitt. (2010) Targeted cellular immunotherapy for leukemia patients. Transfusion and Apheresis Science 43:2, pages 207-210.
Crossref
Crossref
Daniel E. Speiser & Pedro Romero. (2010) Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity. Seminars in Immunology 22:3, pages 144-154.
Crossref
Crossref
Elaine M. Sloand & A.J. Barrett. (2010) Immunosuppression for Myelodysplastic Syndrome: How Bench to Bedside to Bench Research Led to Success. Hematology/Oncology Clinics of North America 24:2, pages 331-341.
Crossref
Crossref
Knut Liseth, Elisabeth Ersvær, Tor Hervig & Øystein Bruserud. (2010) Combination of Intensive Chemotherapy and Anticancer Vaccines in the Treatment of Human Malignancies: The Hematological Experience. Journal of Biomedicine and Biotechnology 2010, pages 1-15.
Crossref
Crossref
Martin A. Cheever, James P. Allison, Andrea S. Ferris, Olivera J. Finn, Benjamin M. Hastings, Toby T. Hecht, Ira Mellman, Sheila A. Prindiville, Jaye L. Viner, Louis M. Weiner & Lynn M. Matrisian. (2009) The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research. Clinical Cancer Research 15:17, pages 5323-5337.
Crossref
Crossref
Javier Pinilla-IbarzBijal ShahJason A. Dubovsky. (2009) The Biological Basis for Immunotherapy in Patients with Chronic Mye-logenous Leukemia. Cancer Control 16:2, pages 141-152.
Crossref
Crossref
Evelien L.J.M. Smits, Zwi N. Berneman & Viggo F.I. Van Tendeloo. (2009) Immunotherapy of Acute Myeloid Leukemia: Current Approaches. The Oncologist 14:3, pages 240-252.
Crossref
Crossref